Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial (Q87908797)
Jump to navigation
Jump to search
COVID19 related scientific article describing effective therapy
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial |
COVID19 related scientific article describing effective therapy |
|
Statements
2 references
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial (English)
0 references
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (English)
2 references
Philippe Parola
2 references
Jean-Marc Rolain
2 references
Philippe Colson
2 references
Didier Raoult
2 references
Bernard La Scola
2 references
Philippe Brouqui
2 references
Jean-Christophe Lagier
2 references
Morgane Mailhe
2 references
Line Meddeb
2 references
Barbara Doudier
2 references
Van Thuan Hoang
2 references
Vera Esteves Vieira
2 references
Johan Courjon
2 references
Hervé Tissot Dupont
2 references
Philippe Gautret
2 references
Valérie Giordanengo
2 references
Stéphane Honoré
2 references
Eric Chabrière
2 references
17 March 2020
0 references
20 March 2020
2 references
0 references
0 references
2 references
56
0 references
105949
2 references
1
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references